Answers are grounded in this paper and cite their sources.
Experimental study demonstrates that extinction-restraint prevents fear relapse via locus coeruleus dopamine D2 modulation of amygdala engrams, highlighting novel PTSD therapy targets.
Despite undergoing exposure therapy, individuals with post-traumatic stress disorder (PTSD) frequently experience relapses when confronted with trauma reminders. This study examined the impact of extinction-restraint intervention (Ext-Res) in a PTSD-related fear relapse model. We found that reactivation of basolateral amygdala engram cells (BLA engram ) correlates with relapse following fear reinstatement. Post-extinction BLA engram activation induced fear relapse, whereas Ext-Res effectively protected relapse and facilitated BLA engram reactivation. Our investigation into the neural circuitry connecting the tyrosine hydroxylase (TH)-positive locus coeruleus neurons (LC TH ) and BLA engram revealed that dopamine release, but not norepinephrine, is crucial for the deactivation of BLA engram following Ext-Res. Manipulation of the LC-BLA circuit could either replicate or reverse the therapeutic effects of Ext-Res. Notably, dopamine D2 receptors emerged as vital mediators of these effects. Overall, we reveal that Ext-Res intervention disrupts fear memory encoded in BLA engram through dopamine D2 receptor-dependent manner, providing new insights into potential therapeutic strategies for preventing relapse in PTSD.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: